Diabetic Kidney Disease
136
24
34
52
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
19 trials with published results (14%)
Research Maturity
52 completed trials (38% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.6%
13 terminated out of 136 trials
80.0%
-6.5% vs benchmark
18%
24 trials in Phase 3/4
37%
19 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (136)
Dosimetry of Tc-99m-Tilmanocept
Mechanisms of Diabetic Nephropathy in Ecuador
Mechanisms of Diabetic Kidney Disease in American Indians
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study
NAD Augmentation in Diabetes Kidney Disease
Pentoxifylline in Diabetic Kidney Disease
Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
The Hong Kong Diabetes Biobank
Immune System in Diabetic Kidney Disease
Formoterol in Diabetes
Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
Gut Microbiota and Serum Metabolites as Predictors of Glycemic Variability and Outcomes in Diabetic Kidney Disease
"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors